Abstract

Seaweeds have bioactive compounds of interest in the pharmaceutical industry. In India, seaweeds are used exclusively for phycocolloids production and have not yet received consideration as a dietary supplement. So, it has become imperative to explore the biomedical potential of seaweeds and promote their utilization as a functional food. The seaweeds Turbinaria ornata, Gracillaria crassa and Laurencia papillosa, collected from the Tuticorin coast of the Southeast coast of India and selected based on preliminary screening, were extracted with acetone and evaluated for antiulcer, wound healing and hepatoprotective activities. L. papillosa showed the highest level of gastric protection activity (81%) at 200 mg/kg, comparable to the standard drug ranitidine (90%). G. crassa followed with 76%. G. crassa and L. papillosa, showed marked wound-healing activity. G. crassa at 200 mg/kg, showed a marked effect on the serum marker enzymes indicating prominent hepatoprotective activity. The noteworthy wound-healing and hepato-protective properties of G. crassa besides anti-ulcer activity next to L. papillosa were indicative of its potential for further consideration.

Highlights

  • Plants and terrestrial microorganisms have been the focus of the search for new drug leads

  • The acetone extract of Gracilaria crassa and Laurencia papillosa significantly reduced the total volume of gastric juice, free and total acidity of gastric secretion and Na+ content of gastric juice at 200 mg/kg concentration

  • The percentage of antiulcer activity of seaweed L. papillosa and G. crassa at 200 mg/kg were comparable to the performance of the standard drug Ranitidine

Read more

Summary

Introduction

Plants and terrestrial microorganisms have been the focus of the search for new drug leads. The chemical novelty associated with such natural products offer great scope, as scientists are on the lookout for novel drug leads to combat the increasing incidence of infectious diseases and the development of resistance to existing pharmaceuticals. In this context, marine organisms such as bacteria, fungi, algae, sponges, soft corals, tunicates, molluscs and bryozoans have been shown to be the potential sources of novel and biologically active natural compounds with numerous pharmacological potentialities (Faulkner, 2000). The lower prevalence of breast and prostate cancer in Japan and China has been linked directly to seaweeds that are consumed in appreciable quantities in these countries than in North America and Europe (Pisani et al, 2002)

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.